Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Downing, Nancy R.a | Lourens, Spencerb | De Soriano, Isabellac | Long, Jeffrey D.c; d | Paulsen, Jane S.c; e; f; * | for the PREDICT-HD Investigators and Coordinators of the Huntington Study Group
Affiliations: [a] Texas A&M College of Nursing, Bryan, TX, USA | [b] Department of Biostatistics, Indiana University School of Medicine, Indianapolis, IN, USA | [c] Department of Psychiatry, Carver College of Medicine, University of Iowa, Iowa City, IA, USA | [d] Department of Biostatistics, College of Public Health, The University of Iowa, Iowa City, IA, USA | [e] Department of Neurology, Carver College of Medicine, The University of Iowa, Iowa City, IA, USA | [f] Department of Psychological and Brain Sciences, The University of Iowa, Iowa City, IA, USA
Correspondence: [*] Correspondence to: Jane S. Paulsen, PhD, University of Iowa Carver College of Medicine, 1-305 MEB, Iowa City, IA 52242-1000, USA. Tel.: +1 319 353 4551; Fax: +1 319 353 4438; E-mail: [email protected].
Abstract: Background: Huntington disease (HD) is a neurodegenerative disease caused by a CAG repeat expansion on chromosome 4. Pathology is associated with CAG repeat length. Prior studies examining people in the intermediate allele (IA) range found subtle differences in motor, cognitive, and behavioral domains compared to controls. Objective: The purpose of this study was to examine baseline and longitudinal differences in motor, cognitive, behavioral, functional, and imaging outcomes between persons with CAG repeats in three ranges: normal (≤26), intermediate (27–35), and reduced penetrance (36–39). Methods: We examined longitudinal data from 389 participants in three allele groups: 280 normal controls (NC), 21 intermediate allele [IA], and 88 reduced penetrance [RP]. We used linear mixed models to identify differences in baseline and longitudinal outcomes between groups. Three models were tested: 1) no baseline or longitudinal differences; 2) baseline differences but no longitudinal differences; and 3) baseline and longitudinal differences. Results: Model 1 was the best fitting model for most outcome variables. Models 2 and 3 were best fitting for some of the variables. We found baseline and longitudinal trends of declining performance across increasing CAG repeat length groups, but no significant differences between the NC and IA groups. Conclusion: We did not find evidence to support differences in the IA group compared to the NC group. These findings are limited by a small IA sample size.
Keywords: Huntington disease, intermediate alleles
DOI: 10.3233/JHD-160185
Journal: Journal of Huntington's Disease, vol. 5, no. 4, pp. 357-368, 2016
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]